DIGITAL EDITION

ARCHIVES

Category: Substance Use Disorders

Marijuana and Body Weight

by Randy A. Sansone, MD, and Lori A. Sansone, MD R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine

Letter to the Editor: The Relation Between Body Mass Index and Substance Use: A true Can of Worms

by Adrian Meule, Dipl-Psych From the Institute of Psychology, University of Wurzburg, Wurzburg, Germany Innov Clin Neurosci. 2014;11(3–4):10–13

Prescription Monitoring Programs: To Use or Not to Use

by Kathryn E. Heagerty, BSN, JD Professional Risk Management Services, Inc., Arlington, VA Innov Clin Neurosci. 2013;10(11–12):28–30

Letter to the editor: Buprenorphine/ Naloxone Treatment in the Correctional Setting—Use or Misuse

Dear Editor: Over 50 percent of the incarcerated population in the United States have a history substance abuse, and it has been noted that over 200,000 of the incarcerated population

A Case of Reversible Neuropsychiatric Symptoms in HIV due to Toxic Leukoencephalopathy

by Michelle C. Liu, BA; Amir Garakani, MD; Katherine A. Krauskopf, MD, MPH; and Jessica Robinson-Papp, MD Ms. Liu is from the Icahn School of Medicine at Mount Sinai, New

Obesity and Substance Misuse: Is There a Relationship?

by Randy A. Sansone, MD, and Lori A. Sansone, MD R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine

Letter to the Editor—“Meow Meow” (Mephedrone) and Catatonia

Venkata Kolli, MBBS; Asish Sharma, MD; Mojgan Amani, MD; Durga Bestha, MBBS, Rajeev Chaturvedi, MBBS Dr. Kolli is Resident,Creighton-Nebraska Psychiatry Residency Program, Omaha, Nebraska; Dr. Sharma is Associate Professor, Department

Letter to the editor: Treatment with Aripiprazole and Levetiracetam in a Subject with Binge Drinking Disorder: A Case Report

Vincenzo M. Romeo, MD; Antonio Bruno, MD, PhD; Umberto Micò, MD, PhD; Rocco A. Zoccali, MD; and Maria Rosaria A. Muscatello, MD, PhD Drs. Romeo, Bruno, Micó, Zoccali, and Musca

New Uncontrolled Benzodiazepine, Phenazepam, Emerging drug of Abuse

Adegboyega Oyemade, MD Board Certified Addiction Psychiatrist, Southern Illinois Healthcare Foundation Behavioral Health Clinic, Belleville, Illinois

A Urinalysis-based Comparative Study of Treatment Adherence on Buprenorphine and Buprenorphine/Naloxone Combination Used as Opioid Substitution Therapy

by Yatan Pal Singh Balhara, MD, DNB (Psychiatry), MNAMS, and Raka Jain, PhD, CChem FRSC Dr. Balhara is Assistant Professor of Psychiatry, National Drug Dependence Treatment Center (NDDTC), All India

Illicit drug use in teenagers and young adults

Dear Editor: I found the review article by Ali et al, “Early Detection of Illicit Drug Use in Teenagers” [Innov Clin Neurosci. 2011;8(12):25–34], to be quite informative and interesting. This

Early Detection of Illicit Drug Use in Teenagers

  by Shahid Ali, MD; Charles P. Mouton, MD; Shagufta Jabeen, MD; Ejike Kingsley Ofoemezie, MD; Rhan K. Bailey, MD; Madiha Shahid, MS; and Qiang Zeng, MD All from Meharry